[1]Patent:US2003/69257,2003,A1
[1]CurrentPatentAssignee:LIGANDPHARMACEUTICALSINC-US2004/14780,2004,A1
[1]Patent:US2004/14780,2004,A1
1796-73-2
32405-76-8
32405-70-2
90008-37-0
193070-18-7
58246-00-7 | (2-Acetyl-1,2-dihydroisoquinolin-1-yl)acetic acid | AA00EMOR | MFCD00704238
62557-53-3 | 1-benzoxepin-3,5(2H,4H)-dione | AA00EOP2 | MFCD18976062
5798-80-1 | 3-Bromo-2-butanol | AA00EQL7 | MFCD19301016
59252-75-4 | 7,8-Dichloro-5-nitroquinoline | AA00ESS8 | MFCD00958267
61325-80-2 | Flumezapine | AA00EVND | MFCD00866715
63696-48-0 | 3-(2-Hydroxy-ethyl)-imidazolidine-2,4-dione | AA00EYQI | MFCD09261155
57073-56-0 | 2-Methyl-4-oxo-4H-pyrido[1,2-a]pyrimidine-9-carboxylic acid | AA00F0NY | MFCD09864100
59647-24-4 | 7-hydroxyisoquinolin-1(2H)-one | AA00F279 | MFCD12024481
6483-96-1 | 4,6-diphenyl-pyriMidine-2-carboxylic acid | AA00F3S2 | MFCD00194910
63779-90-8 | α-Methyl-4-amyl-2,5-dimethoxyphenethylamine | AA00F6B3